Article citationsMore>>

Griffiths, C., Da Silva, K.M., Leathlean, C., Jiang, H., Ang, C.S. and Searle, R. (2022) Investigation of Physical Activity, Sleep, and Mental Health Recovery in Treatment Resistant Depression (TRD) Patients Receiving Repetitive Transcranial Magnetic Stimulation (RTMS) Treatment. Journal of Affective Disorders Reports, 8, Article 100337.
https://doi.org/10.1016/j.jadr.2022.100337

has been cited by the following article:

• TITLE: “Flow” Transcranial Direct Current Stimulation (tDCS) for Depression Treatment in a Primary Healthcare General Practice—An Open-Label Cohort Study Measuring Montgomery-Åsberg Depression Rating Scale (MADRS-S) Outcomes

  AUTHORS: Chris Griffiths, Harmony Jiang, David Smart, Azhar Zafar

  KEYWORDS: Depression, Transcranial Direct Current Stimulation, Wellbeing, General Practice

  JOURNAL NAME: Open Journal of Psychiatry, Vol.14 No.4, July 29, 2024

  ABSTRACT: Background: Flow FL-100 is a transcranial direct current stimulation (tDCS) device self-administered by a patient at home in combination with a software application delivered wellbeing behaviour therapy training. tDCS has evidence of effectiveness in treating symptoms of depression. Purpose/Aim: This post marketing study evaluated the effect of Flow on depression for primary care general practice patients with depression symptoms. Methods: Open-label patient cohort design with no control group. Inclusion criteria were aged 18 years or over and reporting depression symptoms. Participants self-administered five 30 minute tDCS sessions per week for the first three weeks, and then 3 sessions per week following this. Three, six and ten week assessment with participant self-report measure: Montgomery- Åsberg Depression Rating Scale (MADRS-S). Results: MADRS-S remission rates were between 29% - 30% at three weeks, 33% - 34% at six-weeks and 50% at 10-weeks treatment. There was a significant improvement in MADRS-S with large effect sizes at all time points. Conclusions: Flow tDCS can be delivered through a primary healthcare general practice service and patients will choose to use. Flow tDCS provides an effective depression treatment in addition and as an alternative to antidepressants and psychotherapy. tDCS has evidence as an effective depression treatment, and the widespread availability of tDCS in primary care general practice should be considered.